Clinical trial
A Phase 1B/2 Multicohort Umbrella Study to Evaluate the Safety and Efficacy of Novel Treatments And/Or Combinations of Treatments in Participants With Ovarian Cancer (OPAL)
NCT03574779 is registered in ClinicalTrials.gov with Tesaro, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1B/2 Multicohort Umbrella Study to Evaluate the Safety and Efficacy of Novel Treatments And/Or Combinations of Treatments in Participants With Ovarian Cancer (OPAL)
- Lead sponsor
- Tesaro, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 15, 2018
- Completion date
- March 31, 2025
- Enrollment
- 77 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.